BioSpace News Archive

RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company’s novel SkinGun™ is now being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London

AnPac Bio-Medical Science Co., Ltd. is a biotechnology company with operations in China and the United States focused on early cancer screening and detection.

OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead’s cash tender offer for Forty Seven, Inc. expired at 11:59 p.m. on March 27, 2020.

New Site in Sarasota, FL, Increases Akron’s US Manufacturing Capacity for Cell and Gene Therapy Materials and Technologies

Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, announced today the appointment of Kristin Keller to the newly created position of Chief Commercial Officer. Kristin will be focused on driving the global

- VGX-3100 DNA medicine reduced qualifying high-risk HPV 16/18-associated precancerous vulvar lesion area in 80% of patients (by 60% on average); completely curing vulvar dysplasia with no virus detectable in 20% of patients - Data to be presented at the 2020 American Society for Colposcopy and Cervical Pathology (ASCCP) meeting [30-March-2020] PLYMOUTH MEETIN

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2020 results on Wednesday, April 29, 2020 at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its first quarter 2020 results prior to the call. A live audio webcast of the conference call will be available on the Investor Relations section of the LivaNova

Susan G. Komen®, the world’s leading breast cancer organization, announced today the creation of a new Komen COVID-19 Action Fund to help the organization support the unique needs of people facing breast cancer during this health and economic crisis.

Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.